Dataset Information

Real-world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot.

ABSTRACT: In prior work, Friends of Cancer Research convened multiple data partners to establish standardized definitions for oncology real-world end points derived from electronic health records (EHRs) and claims data. Here, we assessed the performance of real-world overall survival (rwOS) from data sets sourced from EHRs by evaluating the ability of the end point to reflect expected differences from a previous randomized controlled trial across five data sources, after applying inclusion/exclusion criteria. The KEYNOTE-189 clinical trial protocol of platinum doublet chemotherapy (chemotherapy) vs. programmed cell death protein 1 (PD-1) in combination with platinum doublet chemotherapy (PD-1 combination) in first-line nonsquamous metastatic non-small cell lung cancer guided retrospective cohort selection. The Kaplan-Meier product limit estimator was used to calculate 12-month rwOS with 95% confidence intervals (CIs) in each data source. Cox proportional hazards models estimated hazard ratios (HRs) and associated 95% CIs, controlled for prognostic factors. Once the inclusion/exclusion criteria were applied, the five resulting data sets included 155 to 1,501 patients in the chemotherapy cohort and 36 to 405 patients in the PD-1 combination cohort. Twelve-month rwOS ranged from 45% to 58% in the chemotherapy cohort and 44% to 68% in the PD-1 combination cohort. The adjusted HR for death ranged from 0.80 (95% CI: 0.69, 0.93) to 1.15 (95% CI: 0.71, 1.85), controlling for age, gender, performance status, and smoking status. This study yielded insights regarding data capture, including ability of real-world data to precisely identify patient populations and the impact of criteria on end points. Sensitivity analyses could elucidate data set-specific factors that drive results.

SUBMITTER: Lasiter L

PROVIDER: S-EPMC9298266 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:BackgroundAs researchers are increasingly interested in real-world studies (RWSs), improving data collection efficiency and data quality has become an important challenge. An electronic source (eSource) generally includes direct capture, collection, and storage of electronic data to simplify clinical research. It can improve data quality and patient safety and reduce clinical trial costs. Although there are already large projects on eSource technology, there is a lack of experience in using eSource technology to implement RWSs. Our team designed and developed an eSource record (ESR) system in China. In a preliminary prospective study, we selected a cosmetic medical device project to evaluate ESR software's effect on data collection and transcription. As the previous case verification was simple, we plan to choose more complicated ophthalmology projects to further evaluate the ESR.ObjectiveWe aimed to evaluate the data transcription efficiency and quality of ESR software in retrospective studies to verify the feasibility of using eSource as an alternative to traditional manual transcription of data in RWS projects.MethodsThe approved ophthalmic femtosecond laser project was used for ESR case validation. This study compared the efficiency and quality of data transcription between the eSource method using ESR software and the traditional clinical research model of manually transcribing the data. Usability refers to the quality of a user's experience when interacting with products or systems including websites, software, devices, or applications. To evaluate the system availability of ESR, we used the System Usability Scale (SUS). The questionnaire consisted of the following 2 parts: participant information and SUS evaluation of the electronic medical record (EMR), electronic data capture (EDC), and ESR systems. By accessing log data from the EDC system previously used by the research project, all the time spent from the beginning to the end of the study could be counted.ResultsIn terms of transcription time cost per field, the eSource method can reduce the time cost by 81.8% (11.2/13.7). Compared with traditional manual data transcription, the eSource method has higher data transcription quality (correct entry rate of 2356/2400, 98.17% vs 47,991/51,424, 93.32%). A total of 15 questionnaires were received with a response rate of 100%. In terms of usability, the average overall SUS scores of the EMR, EDC, and ESR systems were 50.3 (SD 21.9), 51.5 (SD 14.2), and 63.0 (SD 11.3; contract research organization experts: 69.5, SD 11.5; clinicians: 59.8, SD 10.2), respectively. The Cronbach α for the SUS items of the EMR, EDC, and ESR systems were 0.591 (95% CI -0.012 to 0.903), 0.588 (95% CI -0.288 to 0.951), and 0.785 (95% CI 0.576-0.916), respectively.ConclusionsIn real-world ophthalmology studies, the eSource approach based on the ESR system can replace the traditional clinical research model that relies on the manual transcription of data.

Dataset Information

Real-world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets